Literature DB >> 10982638

Extrahepatic large hepatocellular carcinoma with peritoneal dissemination: multimodal treatment, including four surgical operations.

A Tanaka1, R Takeda, H Yamamoto, H Utsunomiya, R Okamura, M Kataoka, S Mukaihara, Y Yamaoka.   

Abstract

We report a patient with extrahepatically growing large hepatocellular carcinoma (HCC) associated with disseminated intraabdominal tumor and spontaneous tumor bleeding who was treated with four operations, transcatheter arterial embolization, systemic chemotherapy, and hyperthermia. It took 12 months for the multimodal treatment to normalize the alpha-fetoprotein (AFP) level, and remission continued for 6 months. We performed the fourth surgical treatment for a recurrent abdominal tumor involving the small intestine and mesentery, but the patient died 26 months after the first admission. Multimodal treatment, including repeat surgical treatments, for such advanced HCC should be encouraged, to prolong life and to maintain quality of life.

Entities:  

Mesh:

Year:  2000        PMID: 10982638     DOI: 10.1007/s005340070060

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  3 in total

Review 1.  Hepatocellular Carcinoma with Gastrointestinal Involvement: A Systematic Review.

Authors:  Cristiana Marinela Urhut; Larisa Daniela Sandulescu; Liliana Streba; Vlad Florin Iovanescu; Sarmis Marian Sandulescu; Suzana Danoiu
Journal:  Diagnostics (Basel)       Date:  2022-05-19

2.  Successful en bloc resection of primary hepatocellular carcinoma directly invading the stomach and pancreas.

Authors:  Dimitris P Korkolis; Chrysanthi Aggeli; George D Plataniotis; Emmanuel Gontikakis; Helen Zerbinis; Nikitas Papantoniou; Dimitris Xinopoulos; Nikiforos Apostolikas; Perikles P Vassilopoulos
Journal:  World J Gastroenterol       Date:  2009-03-07       Impact factor: 5.742

3.  Jejunal Metastasis from Hepatocellular Carcinoma.

Authors:  Mimari Kanazawa; Takeshi Sugaya; Keiichi Tominaga; Fumiaki Takahashi; Kazuhiro Takenaka; Masakazu Nakano; Hideyuki Hiraishi
Journal:  Intern Med       Date:  2017-12-21       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.